TFAM is a novel mediator of immunogenic cancer cell death.

MLA

Yang, Minghua, et al. “TFAM Is a Novel Mediator of Immunogenic Cancer Cell Death.” OncoImmunology, vol. 7, no. 6, June 2018, p. 1. EBSCOhost, https://doi.org/10.1080/2162402X.2018.1431086.

APA

Yang, M., Li, C., Zhu, S., Cao, L., Kroemer, G., Zeh, H., Tang, D., & Kang, R. (2018). TFAM is a novel mediator of immunogenic cancer cell death. OncoImmunology, 7(6), 1. https://doi.org/10.1080/2162402X.2018.1431086

Chicago

Yang, Minghua, Changfeng Li, Shan Zhu, Lizhi Cao, Guido Kroemer, Herbert Zeh, Daolin Tang, and Rui Kang. 2018. “TFAM Is a Novel Mediator of Immunogenic Cancer Cell Death.” OncoImmunology 7 (6): 1. doi:10.1080/2162402X.2018.1431086.